Summary
The neuronal adhesion molecule, D2-protein, and the marker for mature synapses, D3-protein, were studied by crossed immunoelectrophoresis in postmortem samples of human brain hippocampus and frontal cortex. The samples were obtained from 6 patients with endogenous depression, 6 patients with Parkinson's disease, and 9 controls without known neurological or psychiatric disorders. Both D2-protein and D3-protein were significantly increased in hippocampus of depressed patients compared to controls (32% and 30%, respectively) and compared to Parkinson's disease patients (31% and 24%, respectively). However, no significant change was observed in frontal cortex. Combined with the previously observed increase in the level of D2-like protein in blood plasma from depressed patients the findings may indicate that, at least in some regions of the brain, synaptic turnover is increased during depression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Birkmayer, W., Riederer, P.: Biochemical post-mortem findings in depressed patients. J. Neural Transm.37, 95–109 (1975).
Bock, E., Jørgensen, O. S.: Rat brain synaptic vesicles and synaptic plasma membranes compared by crossed immunoelectrophoresis. FEBS Lett.52, 37–39 (1975).
Clarke, H. M. G., Freeman, T.: Quantitative immunoelectrophoresis of human serum proteins. Clin. Sci.35, 403–413 (1968).
Edelman, G. M.: Modulation of cell adhesion during induction, histogenesis, and perinatal development of the nervous system. Ann. Rev. Neurosci.7, 339–377 (1984).
Fog, R., Pakkenberg, H., Juul, P., Bock, E., Jørgensen, O. S., Andersen, J.: Highdose treatment of rats with perphenazine enanthate. Psychopharmacology50, 305–307 (1976).
Gottfries, C.-G., Oreland, L., Wiberg, Å., Winblad, B.: Lowered monoamine oxidase activity in brains from alcoholic suicides. J. Neurochem.25, 667–673 (1975).
Grote, S. S., Moses, S. G., Robins, E., Hudgens, R. W., Croninger, A. B.: A study of selected catecholamine metabolizing enzymes: A comparison of depressive suicides and alcoholic suicides with controls. J. Neurochem.23, 791–802 (1974).
Harboe, N. M. G., Ingild, A.: Immunization, isolation of immunoglobulins and antibody titre determination. Scand. J. Immunol.17, Suppl. 10, 345–351 (1983).
Hemmingsen, R., Jørgensen, O. S.: Specific brain proteins during severe ethanol intoxication and withdrawal in the rat. Psychiatry Res.3, 1–11 (1980).
Hirn, M., Ghandour, M. S., Deagostini-Bazin, H., Goridis, C.: Molecular heterogeneity and structural evolution during cerebellar ontogeny detected by monoclonal antibody of the cell surface antigen BSP-2. Brain Res.265, 87–100 (1983).
Ibsen, S., Berezin, V., Nørgaard-Pedersen, B., Bock, E.: Enzyme-linked immunosorbent assay of the D2-glycoprotein. J. Neurochem.41, 356–362 (1983).
Jørgensen, O. S.: Neuronal membrane D2-protein during rat brain ontogeny. J. Neurochem.37, 939–946 (1981).
Jørgensen, O. S.: D2-protein and D3-protein as markers for synaptic turnover and concentration. J. Neural Transm., Suppl. 18, pp. 245–255. Wien-New York: Springer. 1983.
Jørgensen, O. S., Bock, E.: Brain specific synaptosomal membrane proteins demonstrated by crossed immunoelectrophoresis. J. Neurochem.23, 879–880 (1974).
Jørgensen, O. S., Bock, E.: Synaptic plasma membrane antigen D2 measured in human cerebrospinal fluid by rocket-immunoelectrophoresis. Determination in psychiatric and neurological patients. Scand. J. Immunol.4, Suppl. 2, 25–30 (1975).
Jørgensen, O. S., Bock, E.: Brain-specific proteins in the occipital cortex of rats housed in enriched and impoverished environments. Neurochem. Res.4, 175–187 (1979).
Jørgensen, O. S., Bolwig, T. G.: Synaptic proteins after electroconvulsive stimulation. Science205, 705–707 (1979).
Jørgensen, O. S., Møller, M.: Immunocytochemical localization of the D2-protein in rat retina. Brain Res.221, 15–26 (1981).
Jørgensen, O. S., DeLouvée, A., Thiery, J.-P., Edelman, G. M.: The nervous system specific protein D2 is involved in adhesion among neuntes from cultured rat ganglia. FEBS Lett.111, 39–42 (1980).
Jørgensen, O. S., Reynolds, G. P., Riederer, P., Jellinger, K.: Parkinson's disease putamen: Normal concentration of synaptic membrane marker antigens. J. Neural Transm.54, 171–179 (1982).
Jørgensen, O. S., Gjerris, A., Rafaelsen, O. J.: Increased dilution of brain extracellular fluid in CSF of depressed and schizophrenic patients marked by neuronal D2-like protein concentration. Clin. Neuropharmacol.7, Suppl. 1, 296–297 (1984 a).
Jørgensen, O. S., Honegger, P., Matthieu, J.-M.: The neuronal adhesion protein D2 in differentiating aggregates of brain cells. Develop. Brains Res.14, 41–49 (1984 b).
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with Folin phenol reagent. J. Biol. Chem.193, 265–275 (1951).
Mogensen, J., Jørgensen, O. S., Divac, I.: Synaptic proteins in frontal and control brain regions of rats after exposure to spatial problems. Behav. Brain Res.5, 375–386 (1982).
Neumayer, E., Riederer, P., Danielczyk, W., Seemann, D.: Biochemische Hirnbefunde bei endogener Depression. Wien. Med. Wschr.125, 344–349 (1975).
Perry, E. K., Marshall, E. F., Blessed, G., Tomlinson, B. E., Perry, R. H.: Decreased imipramine binding in the brains of patients with depressive illness. Brit. J. Psychiat.142, 188–192 (1983).
Peterson, G. L.: A simplification of the protein assay method ofLowry et al. which is more generally applicable. Analyt. Biochem.83, 346–376 (1977).
Riederer, P., Birkmayer, W.: A new concept: Brain area specific imbalance of neurotransmitters in depression syndrome-human brain studies. In: Enzymes and Neurotransmitters in Mental Disease (Usdin, E., Sourkes, T. L., Youdim, M. B. H., eds.), pp. 261–280. New York: J. Wiley. 1980.
Rosenkilde, P., Mogensen, E., Centervall, G., Jørgensen, O. S.: Peaks of neuronal membrane antigen and thyroxine in larval development of the Mexican axolotl. Gen. Comp. Endocrinol.48, 504–514 (1982).
Siegel, S.: Nonparametric Statistics for the Behavioral Sciences, p. 312. New York: McGraw-Hill. 1956.
Stone, E. A.: Problems with current catecholamine hypotheses of antidepressant agents: Speculations leading to a new hypothesis. Behav. Brain Sci.6, 535–577 (1983).
Sugrue, M. F.: Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. Pharmacol. Ther.21, 1–33 (1983).
Sulser, F.: Deamplification of noradrenergic signal transfer by antidepressants: A unified catecholamine-serotonin hypothesis of affective disorders. Psychopharmacol. Bull.19, 300–304 (1983).
Svendsen, P. J., Axelsen, N. H.: A modified antigen-antibody crossed electrophoresis characterizing the specificity and titre of human precipitins againstCandida albicans. J. Immunol. Meth.1, 169–176 (1972).
Van Praag, H. M.: Neurotransmitters and CNS disease. Lancetii, 1259–1264 (1982).
Whybrow, P. C., Mendels, J.: Towards a biology of depression: Some suggestions from neurophysiology. Amer. J. Psychiat.125, 1491–1500 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jørgensen, O.S., Riederer, P. Increased synaptic markers in hippocampus of depressed patients. J. Neural Transmission 64, 55–66 (1985). https://doi.org/10.1007/BF01259345
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01259345